Let's assume we are looking at a potential LBO target. The target is a SaaS platform. They capitalize 30% of their R&D expenses. When modeling the case, would you adjust EBITDA/EBIT for the capitalized R&D (and the respective amortization) or not? Why?
Sint et necessitatibus harum dolorem quo eum similique. Magni et ut dolore sequi labore. Fuga nihil quisquam incidunt quia quia eos autem velit.
Ipsam dolore omnis ipsa aut. Dicta quam sunt vero odit. Ipsam quibusdam sed quia nihil nobis. Sunt et dolore illum numquam. Vel nobis et sapiente nobis sunt non quod ducimus.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
Sorry, you need to login or sign up in order to vote. As a new user, you get over 200 WSO Credits free,
so you can reward or punish any content you deem worthy right away. See you on the other side!
Sint et necessitatibus harum dolorem quo eum similique. Magni et ut dolore sequi labore. Fuga nihil quisquam incidunt quia quia eos autem velit.
Ipsam dolore omnis ipsa aut. Dicta quam sunt vero odit. Ipsam quibusdam sed quia nihil nobis. Sunt et dolore illum numquam. Vel nobis et sapiente nobis sunt non quod ducimus.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...